Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. ConforMIS reports $114M raised since 2011 in latest tally
Orthopedics devices maker ConforMIS is in a fund-raising frenzy, raising $113.8 million since 2011 to develop its custom joint implant technology, according to regulatory filings.
2. J&J: $19.7B Synthes buyout should boost earnings
Johnson & Johnson says it looks like there will be no earnings dilution from its $19.7 billion mega-merger with Swiss orthopedic giant Synthes, thanks to a coffer of overseas cash that will help slash its U.S. tax bill.
1. FDA panel backs Edwards’ Sapien heart valve for lower-risk patients
An FDA advisory panel almost unanimously recommends expanded indication to approve Edwards Lifesciences’ Sapien transcatheter aortic heart valve for lower-risk patients, despite concerns about possible biases in clinical trials.